BMY

4 Pharmaceutical Stocks to Buy Now

Four pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

Diabetes Drug From BMY, AZN Gets Panel Recommendation

A FDA panel has voted to approve a diabetes drug rejected by the agency almost two years ago. More 

5 Pharmaceutical Stocks to Buy Now

This week, five pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More 

4 Pharmaceutical Stocks to Buy Now

Four pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

4 Pharmaceutical Stocks to Buy Now

The grades of four pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

5 Overpriced Stocks to Ditch Now

These stocks are either momentum darlings or supposed bastions of safety, but their valuations aren't justified. More